GeoVax CFO receives 17,600 stock options grant

GeoVax Labs CFO Mark Reynolds received a grant of stock options covering 17,600 shares of common stock.

Rhea-AI Filing Summary

GeoVax Labs CFO Mark Reynolds received a grant of stock options covering 17,600 shares of common stock. The options have an exercise price of $1.18 per share and expire on June 17, 2036. They become exercisable in three equal annual installments on the first three anniversaries of the grant date.

Insider Trade Summary

Grant/Award: 17,600 shares

Grant/Award 1 txn

Insider Reynolds Mark

Role CFO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	17,600	$0.00	$0.00

Holdings After Transaction: Stock Option — 17,600 contracts (Direct)

Footnotes (1)

1. F1. Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Key Figures

Stock options granted: 17,600 options Exercise price: $1.18 per share Expiration date: June 17, 2036 +1 more

4 metrics

Stock options granted 17,600 options Grant to CFO Mark Reynolds on June 17, 2026

Exercise price $1.18 per share Strike price for the 17,600 stock options

Expiration date June 17, 2036 Option term for CFO grant

Post-grant derivative holdings 17,600 options Total stock options held following this transaction

Key Terms

Stock Option, Grant, award, or other acquisition, exercise price, exercisable in three equal annual installments

4 terms

Stock Option financial

"security_title: "Stock Option" tied to common stock as underlying security"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition" for this option"

exercise price financial

"conversion_or_exercise_price of 1.1800 per underlying common share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

exercisable in three equal annual installments financial

"footnote: "Stock option becomes exercisable in three equal annual installments""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did GeoVax Labs (GOVX) disclose about CFO Mark Reynolds in this Form 4?

GeoVax Labs reported that CFO Mark Reynolds received a grant of 17,600 stock options. These options relate to common stock and were awarded as a compensation grant, not an open-market purchase or sale of existing shares.

How many stock options did the GeoVax (GOVX) CFO receive and at what price?

The CFO received 17,600 stock options with an exercise price of $1.18 per share. This price is the amount he would pay per share to convert the options into common stock once they become exercisable.

When do the newly granted GeoVax (GOVX) stock options to the CFO become exercisable?

The stock options become exercisable in three equal annual installments on the first three anniversaries of the grant date. This standard vesting schedule encourages longer-term alignment between the CFO and shareholder interests over multiple years.

What is the expiration date of the GeoVax (GOVX) CFO stock option grant?

The stock options granted to the CFO expire on June 17, 2036. If the options are not exercised by that date, they lapse and can no longer be used to acquire GeoVax common shares under this grant.

Does this GeoVax (GOVX) Form 4 show the CFO buying or selling shares on the market?

The filing does not show any market buy or sell transactions. It reports a compensation-related grant of stock options coded as an acquisition (A), rather than an open-market purchase or sale of GeoVax common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:18 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reynolds Mark

(Last) (First) (Middle)

1955 LAKE PARK DRIVE

SUITE 300

(Street)

SMYRNA GEORGIA 30080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GeoVax Labs, Inc. [ GOVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$1.18	06/17/2026		A		17,600		(1)	06/17/2036	Common Stock	17,600	$0	17,600	D

Explanation of Responses:

1. Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

	/s/ Mark W. Reynolds	06/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)